Victory Capital Management
SLS icon

Victory Capital Management’s SELLAS Life Sciences SLS Stock Holding History

Victory Capital Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.9K Sell
16,048
-303
-2% -$1.36K ﹤0.01% 2296
2025
Q4 		$61.6K Buy
16,351
+4,481
+38% +$8.71K ﹤0.01% 2313
2025
Q3 		$19.1K Buy
11,870
+223
+2% +$397 ﹤0.01% 2399
2025
Q2 		$25.5K Buy
+11,647
New +$17.9K ﹤0.01% 2426
2020
Q2 		– Sell
-2,298
Closed -$4K – 3179
2020
Q1 		$4K Buy
+2,298
New +$5.92K ﹤0.01% 3558
2019
Q4 		– Sell
-793
Closed -$5K – 3190
2019
Q3 		$5K Buy
+793
New +$5.84K ﹤0.01% 3461

Other funds holding SLS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM